Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SH-1028Phase 31 trial
Nanjing Sanhome Pharmaceutical, Co., Ltd. · Non-small Cell Lung Cancer
- SH006Phase 31 trial
Nanjing Sanhome Pharmaceutical, Co., Ltd. · Hepatocellular Carcinoma (HCC)
- SHPL-49Phase 31 trial
Shanghai Hutchison Pharmaceuticals Limited · Acute Ischemic Stroke
- SHR6390Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast Cancer
- SIM0270Phase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Locally Advanced or Metastatic Breast Cancer
- SIM0811Phase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Acute Ischemic Stroke AIS
- SJP-0132Phase 31 trial
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. · Dry Eye
- SKP-0141Phase 31 trial
SK Plasma Co., Ltd. · Hemophilia A, Severe
- SL1002Phase 31 trial
Saol Therapeutics Inc · Osteoarthritis Knee Pain
- SocazolimabPhase 31 trial
Lee's Pharmaceutical Limited · Cervical Cancer
- SP-102Phase 31 trial
Semnur Pharmaceuticals, Inc. · Lumbosacral Radicular Pain
- SRG-514Phase 31 trial
SURGE Therapeutics · TNBC - Triple-Negative Breast Cancer
- SRP-9003Phase 31 trial
Sarepta Therapeutics, Inc. · Limb-girdle Muscular Dystrophy
- STN1013800Phase 31 trial
Santen Pharmaceutical Co., Ltd. · Blepharoptosis
- STSP-0601Phase 31 trial
Jiangsu BioJeTay Biotechnology Co., Ltd. · Hemophilia
- Sub-cutaneous LenacapavirPhase 31 trial
Gilead Sciences · Pre-Exposure Prophylaxis of HIV Infection
- SurufatinibPhase 31 trial
Hutchmed · Metastatic Pancreatic Cancer
- sustained-release gemcitabine-docetaxelNDV-01Phase 31 trial
Relmada Therapeutics, Inc. · Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Urothelial Carcinoma Bladder
- SuvemcitugPhase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Refractory Metastatic Colorectal Cancer
- SUVN-502MasupirdinePhase 31 trial
Suven Life Sciences Limited · Agitation, Alzheimer's Type Dementia
- SYH9056Phase 31 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Mild-to-moderate Essential Hypertension
- T89Phase 31 trial
Tasly Pharmaceuticals, Inc. · Chronic Stable Angina Pectoris
- TAK-330Phase 31 trial
Takeda · Coagulation Disorder
- TAK-928Phase 31 trial
Takeda · IO Resistant Squamous and Nonsquamous NSCLC
- TBI-1301Phase 31 trial
Takara Bio Inc. · Synovial Sarcomas
- TCA108Phase 31 trial
EMS · Hypertension
- TEV-56248Phase 31 trial
Teva · Asthma
- TH07Phase 31 trial
Triple Hair Inc · Androgenic Alopecia
- THP-00101Forxiga Tab.Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00102Micardis Tab., THP-00103Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00104Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00105Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THP-00106Phase 31 trial
THPharm Corp. · Type 2 Diabetes, Hypertension
- THRV-1268Phase 31 trial
Thryv Therapeutics · Long QT Syndrome (LQTS) 2
- TilesizumabBGB-108Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Lung Cancer
- TociluzumabPhase 31 trial
Roche (Genentech) · Relapsed or Refractory Follicular Lymphoma
- Toludesvenlafaxine Hydrochloride Sustained-releasePhase 31 trial
Luye Pharma Group Ltd. · Generalized Anxiety Disorder
- TPN171HSimmerafilPhase 31 trial
Vigonvita Life Sciences · Erectile Dysfunction
- TralesinidasePhase 31 trial
Spruce Biosciences · MPS IIIB
- TSC-101Phase 31 trial
TScan Therapeutics, Inc. · AML, MDS
- TTAX01Phase 31 trial
BioTissue Holdings, Inc · Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer
- TVAV-008Phase 31 trial
Grand Theravac Life Sciences (Nanjing) Co., Ltd. · Chronic hepatitisB
- UtomilumabPhase 31 trial
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- V116Phase 31 trial
Merck & Co. · Pneumococcal Infection
- V181Phase 31 trial
Merck & Co. · Healthy
- varegacestatAL102Phase 31 trial
Immunome, Inc. · Desmoid, Desmoid Tumor
- VC004Phase 31 trial
Jiangsu vcare pharmaceutical technology co., LTD · Locally Advanced Solid Tumor
- VE303Phase 31 trial
Vedanta Biosciences, Inc. · Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence
- VG081821ACVG081821Phase 31 trial
Zhejiang Vimgreen Pharmaceuticals, Ltd. · Parkinson Disease (PD)
- VLA1553Phase 31 trial
Valneva Austria GmbH · Chikungunya Virus Infection
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.